InfuSystem Holdings, Inc.

AMEX:INFU

Medical - Instruments & Supplies

Healthcare
$14.67 +4.00%

+$0.35 today

Market cap
$293.89M
Beta
1.42
P/E (TTM)
23.2
EPS (TTM)
$0.39
52W Low $5.38High $11.04

Volume 0.16M

Average 0.16M

INFU Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

InfuSystem Holdings, Inc.AMEX: INFU

Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026

Cost of revenue declines year over year

Q1 FY2026 cost of revenue of $14M fell 9.9% year over year, behind the -4.5% change in trailing-twelve-month cost of revenue. Sequentially, it fell 11.4% from the prior quarter. Over 3 fiscal years it compounded at +8.6% a year.

Context

  • Cost of revenue amounted to 44.0% of revenue in FY2025, down 3.8 pp from a year earlier.
  • Cost of revenue increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -9.9% toward the trailing-twelve-month pace of -4.5%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$14M-11.4% QoQ
Last fiscal yearDec 2025
$63.14M-2.0% YoY
LTMMar 2026
$61.59M-4.5% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-9.9%——
1 year-2.0%——
3-year CAGR+8.6%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
63.14M USD
Year-over-year change
-2.0%
4-year CAGR
+9.5%

Cost of Revenue vs competitors

How INFU compares with its peers on the latest reported figures

  • INFU's LTM Mar 2026 cost of revenue of $61.59M is the 2nd highest of the 3 companies compared; the peer median is $682.43M.
  • Its year-over-year change of -4.5% is the 2nd highest of 3, against a peer median of +9.3%.
  • Cost of revenue amounts to 43.3% of revenue for INFU, versus a peer median of 50.5%.
INFU Competitors Peer median
Cost of Revenue for INFU and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ICUIICU Medical, Inc.LTM Jun 2026$1.35B -11.4%-3.8%62.4%
INFUInfuSystem Holdings, Inc.LTM Mar 2026$61.59M -4.5%+8.6%43.3%
KRMDKORU Medical Systems, Inc.LTM Mar 2026$16.67M +30.1%+7.4%38.5%
Peer median (excluding INFU) $682.43M+9.3%+1.8%50.5%

Competitors are the stored peer set for INFU. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue102.38M109.91M125.79M134.86M143.44M
Cost of Revenue43.85M49.35M62.68M64.46M63.14M
Gross Profit58.54M60.56M63.11M70.4M80.3M
Gross Margin57.2%55.1%50.2%52.2%56.0%
Research & Development00000
Selling, General & Admin51.45M56.41M58.03M62.52M67.46M
Operating Expenses55.72M58.91M59.02M63.51M68.38M
Depreciation & Amortization14.63M13.36M12.51M12.5M13.29M
EBITDA17.26M14.89M16.53M20.03M25.22M
EBITDA Margin16.9%13.5%13.1%14.9%17.6%
Operating Income2.82M1.65M4.09M6.89M11.92M
Operating Margin2.8%1.5%3.2%5.1%8.3%
Interest Income00000
Interest Expense1.38M1.4M2.17M1.78M1.3M
Other Income / Expenses(1.56M)(1.52M)(2.24M)(1.83M)(1.3M)
Income Before Tax1.26M130K1.85M5.06M10.62M
Pre-Tax Margin1.2%0.1%1.5%3.8%7.4%
Income Tax Expense(163K)112K979K2.71M4M
Net Income1.42M18K872K2.35M6.63M
Net Margin1.4%0.0%0.7%1.7%4.6%
EPS (Basic)0.070.000.040.110.32
EPS (Diluted)0.060.000.040.110.31
Weighted Avg Shares20.52M20.65M21.02M21.27M20.66M
Weighted Avg Shares (Diluted)22.05M21.55M21.65M21.71M21.1M

InfuSystem Holdings, Inc.

AMEX:INFU

Intrinsic Alpha fair value

Locked

Current Price

$14.67

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.